Editorialhttps://hdl.handle.net/20.500.12805/44902026-11-11T00:11:06Z2026-11-11T00:11:06ZEmerging issues in COVID-19 vaccination in tropical areas: Impact of the immune response against helminths in endemic areasChacin-Bonilla, L.Chacón-Fonseca, N.Rodriguez-Morales, A.J.https://hdl.handle.net/20.500.12805/46902025-10-31T18:32:33Z2021-01-01T00:00:00ZEmerging issues in COVID-19 vaccination in tropical areas: Impact of the immune response against helminths in endemic areas
Chacin-Bonilla, L.; Chacón-Fonseca, N.; Rodriguez-Morales, A.J.
Researchers worldwide are trying to find valuable drugs against the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Some of them focused as antivirals, others targeted in other ways (e.g. immunomodulation) to relieve the symptoms of the infected patients and help lower the death toll throughout the world. Unfortunately, there is a lack of effective drugs to manage COVID-19. The hopeful and long-awaited development of vaccines and the approval of their use in humans is a fact. The time consuming that it Will take to achieve herd immunity due to waiting for the availability and distribution of the vaccines is a reality in full swing and shows significant health inequalities...
2021-01-01T00:00:00ZWorld tuberculosis day 2023 – Reflections on the spread of drug-resistant tuberculosis by travellers and reducing risk in forcibly displaced populationsRodriguez-Morales, A.J.Abbara, A.Ntoumi, F.Kapata, N.Mwaba, P.Yeboah-Manu, D.Maeurer, M.Dar, O.Abubakar, I.Zumla, A.https://hdl.handle.net/20.500.12805/46932026-10-24T08:01:31Z2023-01-01T00:00:00ZWorld tuberculosis day 2023 – Reflections on the spread of drug-resistant tuberculosis by travellers and reducing risk in forcibly displaced populations
Rodriguez-Morales, A.J.; Abbara, A.; Ntoumi, F.; Kapata, N.; Mwaba, P.; Yeboah-Manu, D.; Maeurer, M.; Dar, O.; Abubakar, I.; Zumla, A.
World Tuberculosis (TB) Day, March 24th, 2023, will commemorate the day in 1882 when Professor Robert Koch announced his discovery of Mycobacterium tuberculosis (Mtb) when TB ravaged Europe. Over a century later, in 1993, the World Health Organization (WHO) declared TB a global health emergency. Since then, there have been 60 million deaths due to TB. The tragic state of affairs reflects a great paradox – that, despite affordable and effective TB treatment being available for the past seven decades, the latest 2022 WHO Annual Global Tuberculosis Report highlights that TB remains a leading cause of ill health and death from an infectious disease worldwide...
2023-01-01T00:00:00ZCOVID-19 and mucormycosis in Latin America – An emerging concernRodriguez-Morales, A.J.Mamani-García, C.S.Nuñez-Lupaca, J.N.León-Figueroa, D.A.Olarte-Durand, M.Yrene-Cubas, R.A.Ticona, D.M.Abanto-Urbano, S.https://hdl.handle.net/20.500.12805/46922026-10-25T08:01:55Z2021-01-01T00:00:00ZCOVID-19 and mucormycosis in Latin America – An emerging concern
Rodriguez-Morales, A.J.; Mamani-García, C.S.; Nuñez-Lupaca, J.N.; León-Figueroa, D.A.; Olarte-Durand, M.; Yrene-Cubas, R.A.; Ticona, D.M.; Abanto-Urbano, S.
During the Coronavirus Disease 2019 (COVID-19) pandemic, the improper use of corticosteroids and the presence of diabetes mellitus in patients marked the beginning of an increased incidence of fungal infections such as aspergillosis and mucormycosis in patients with this emerging viral infection. Mucormycosis is a common angioinvasive infection with significant morbidity and mortality now complicating the course of, especially severe, COVID-19. The disease spectrum comprises rhino-orbito-cerebral, pulmonary, cutaneous, gastrointestinal and disseminated mucormycosis...
2021-01-01T00:00:00ZAvian influenza spillover to humans: Are we prepared to deal with another potential pandemic?Ahmad, F.Haque, S.Tawil, S.Husni, R.Bonilla-Aldana, D.K.Montenegro-Idrogo, J.J.Rodriguez-Morales, A.J.https://hdl.handle.net/20.500.12805/46912026-10-31T08:01:34Z2023-01-01T00:00:00ZAvian influenza spillover to humans: Are we prepared to deal with another potential pandemic?
Ahmad, F.; Haque, S.; Tawil, S.; Husni, R.; Bonilla-Aldana, D.K.; Montenegro-Idrogo, J.J.; Rodriguez-Morales, A.J.
Avian influenza, known as bird flu, is caused by influenza type-A viruses, primarily adapted to bird species, including domesticated and poultry. Bird flu can infect entire flocks within days and is transmitted through respiratory secretions, faeces and saliva [1–3]. The transmission can occur directly and through contaminated feed and water. Notably, bird flu viruses are extraordinarily resistant and can survive for prolonged periods, even in low temperatures [1–3]. Based on pathogenicity standards, avian flu strains are divided into high pathogenic and low pathogenic. The highly pathogenic avian influenza (HPAI), a highly transmissible variation of bird flu, is linked predominantly to the H5N1 and H7N9 strains of influenza type-A viruses.
2023-01-01T00:00:00Z